Final published version
Research output: Contribution to Journal/Magazine › Review article › peer-review
Research output: Contribution to Journal/Magazine › Review article › peer-review
}
TY - JOUR
T1 - Chapter 3 The GlcNAc-PI de-N-acetylase. Structure, function, and activity
AU - Urbaniak, Michael D.
AU - Ferguson, Michael A J
PY - 2009/12/1
Y1 - 2009/12/1
N2 - The N-acetylglucosamine phosphatidylinositol (GlcNAc-PI) de-. N-acetylase catalyzes the removal of the N-acetyl group from GlcNAc-PI in the second step of GPI biosynthesis. The GlcNAc-PI de-. N-acetylase is a 252-residue integral membrane protein containing a single N-terminal membrane spanning domain, with the majority of the protein on the cytoplasmic face of the ER. Site-directed mutagenesis studies have lead to the proposal of a zinc-dependent mechanism of action analogous to zinc peptidases. The activity of the GlcNAc-PI de-. N-acetylase can be measured both in vivo and in vitro, and active recombinant protein has been obtained. The enzyme is a potential drug target for the treatment of African sleeping sickness, and differences in substrate recognition and channeling between mammalian and trypanosomal enzymes have been exploited to produce species-specific inhibitors.
AB - The N-acetylglucosamine phosphatidylinositol (GlcNAc-PI) de-. N-acetylase catalyzes the removal of the N-acetyl group from GlcNAc-PI in the second step of GPI biosynthesis. The GlcNAc-PI de-. N-acetylase is a 252-residue integral membrane protein containing a single N-terminal membrane spanning domain, with the majority of the protein on the cytoplasmic face of the ER. Site-directed mutagenesis studies have lead to the proposal of a zinc-dependent mechanism of action analogous to zinc peptidases. The activity of the GlcNAc-PI de-. N-acetylase can be measured both in vivo and in vitro, and active recombinant protein has been obtained. The enzyme is a potential drug target for the treatment of African sleeping sickness, and differences in substrate recognition and channeling between mammalian and trypanosomal enzymes have been exploited to produce species-specific inhibitors.
U2 - 10.1016/S1874-6047(09)26003-3
DO - 10.1016/S1874-6047(09)26003-3
M3 - Review article
AN - SCOPUS:77954838969
VL - 26
SP - 49
EP - 64
JO - Enzymes
JF - Enzymes
SN - 1874-6047
IS - C
ER -